医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Harlan Laboratories Announces Invenium Pharmacology as Agent for Southeast Asia, Australia and New Zealand

2014年04月23日 PM05:00
このエントリーをはてなブックマークに追加


 

ITINGEN, Switzerland

Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services, announces the appointment of Invenium Pharmacology as its exclusive agent for Harlan’s Contract Research Services (CRS) in Australia, Southeast Asia and New Zealand.

Through the agency agreement, Harlan CRS will strengthen its local presence in the pharmaceutical and chemical industries across the region. Anthony Bishop of Invenium Pharmacology will take on the primary contact role in the region.

With more than 15 years of experience in pharmaceutical companies and contract research organizations, Bishop brings extensive experience in business development, global project management and sales to Harlan CRS.

As the local agent for Harlan CRS, Bishop will provide leadership and management expertise to connect drug development companies with the services and insight they need to advance their programs. This agreement also positions Harlan CRS for continued growth on a global scale.

“There are great growth opportunities for Harlan CRS in this region,” said Ciriaco Maraschiello, director of strategic initiatives and director of drug discovery and translational medicine at Harlan CRS. “Working with Anthony Bishop and Invenium Pharmacology, we can provide the expertise that companies and organizations in this region need — at a local level.”

About Harlan Laboratories, Ltd.

Harlan Laboratories, Ltd., a subsidiary of Harlan Laboratories, Inc., provides general and specialty toxicology services through its Contract Research Services business to the global chemical, agrochemical and pharmaceutical industries. With laboratory locations in Germany, Spain, Switzerland and the UK, Harlan and its affiliates are focused on providing customers with services to optimize product development. Please visit www.Harlan.com/CRS.

CONTACT

For Harlan Laboratories, Ltd.
Lea Studer, +1 308-237-5567
lea@scorrmarketing.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • CANbridge Pharmaceutical and WuXi Biologics Enter into Strategic Partnership for Rare Disease Therapeutics
  • 武田呈报3期ALTA-1L试验结果,显示在晚期ALK+非小细胞肺癌一线治疗中,ALUNBRIG® (brigatinib)的颅内有效性优于克唑替尼
  • Philip Morris International Launches Next Generation of IQOS, the World’s Leading Heated Tobacco Product
  • PotNetwork Holdings, Inc.第三季度业绩创纪录,营收超过610万美元
  • ポットネットワーク・ホールディングスが610万ドルを超える収益で過去最高の第3四半期を終える